RASSF1 and neoplasm: As observed in this study, RASSF1A epigenetic silencing is robust and widespread within the RASSF1A promoter in breast, thyroid and neuroblastoma tumor tissues and cell lines, whereas in CRC tumor tissues and cell lines, methylation of RASSF1A is not widespread over the 32 CpGs explored in this study.